参考文献/References:
[1] Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation(ATRIA)Study[J]. JAMA,2001,285(18):2370-2375.
[2] 周自强, 胡大一, 陈捷,等. 中国心房颤动现状的流行病学研究[J]. 中华内科杂志,2004, 43(7):491-494.
[3] Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation[J]. Eur Heart J,2010,31(8):967-975.
[4] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation,2014,130(23):2071-2104.
[5] European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2010,31(19):2369-2429.
[6] Lickfett L, Hackenbroch M, Lewalter T, et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation[J]. J Cardiovasc Electrophysiol,2006,17(1):1-7.
[7] Sakamoto T, Kumagai K, Nishiuchi S, et al. Predictors of asymptomatic cerebral infarction associated with radiofrequency catheter ablation for atrial fibrillation using an irrigated-tip catheter[J]. Europace,2013,15(3):332-338.
[8] Gaita F, Leclercq JF, Schumacher B, et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon[J]. J Cardiovasc Electrophysiol,2011,22(9):961-968.
[9] Herrera Siklódy C, Deneke T, Hocini M, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study[J]. J Am Coll Cardiol,2011,58(7):681-688.
[10] Deneke T, Shin DI, Balta O, et al. Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging[J]. Heart Rhythm,2011,8(11):1705-1711.
[11] Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline[J]. N Engl J Med,2003,348(13):1215-1222.
[12] Gaita F, Caponi D, Pianelli M, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation[J]. Circulation,2010,122(17):1667-1673.
[13] Deneke T, Jais P, Scaglione M, et al. Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review[J]. J Cardiovasc Electrophysiol,2015,26(4):455-463.
[14] Srinivasan A, Goyal M, Azri FA, et al. State-of-the-art imaging of acute stroke[J]. Radiographics,2006,26(suppl 1):S75-S95.
[15] Brant-Zawadzki M, Atkinson D, Detrick M, et al. Fluid-attenuated inversion recovery(FLAIR)for assessment of cerebral infarction.Initial clinical experience in 50 patients[J]. Stroke,1996,27(7):1187-1191.
[16] Thomalla G, Cheng B, Ebinger M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset(PRE-FLAIR): a multicentre observational study[J]. Lancet Neurol,2011,10(11):978-986.
[17] Haines DE, Stewart MT, Barka ND, et al. Microembolism and catheter ablation Ⅱ effects of cerebral microemboli injection in a canine model[J]. Circ Arrhythm Electrophysiol,2013,6(1):23-30.
[18] Thomalla G, Rossbach P, Rosenkranz M, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less[J]. Ann Neurol,2009,65(6):724-732.
[19] Liu S, Xu X, Cheng Q, et al. Simple quantitative measurement based on DWI to objectively judge DWI-FLAIR mismatch in a canine stroke model[J]. Diagn Interv Radiol Ank Turk, 2015,21(4):348-354.
[20] Haeusler KG, Koch L, Herm J, et al. 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study[J]. J Cardiovasc Electrophysiol,2013,24(1):14-21.
[21] Gaita F, Corsinovi L, Anselmino M, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function[J]. J Am Coll Cardiol,2013,62(21):1990-1997.
[22] Liebetrau M, Steen B, Hamann GF, et al. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality:a population-based study in 85-year-old subjects[J]. Stroke J Cereb Circ,2004,35(8):1816-1820.
[23] Schrickel JW, Lickfett L, Lewalter T, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation[J]. Europace, 2010,12(1):52-57.
[24] di Biase L, Gaita F, Toso E, et al. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study[J]. Heart Rhythm,2014,11(5):791-798.
[25] Santangeli P, di Biase L, Burkhardt JD, et al. Catheter ablation of atrial fibrillation under therapeutic warfarin should be adopted worldwide: let's stop waiting for Godot! [J]. J Cardiovasc Electrophysiol,2013,24(5):516-518.
[26] Müssigbrodt A, Grothoff M, Dinov B, et al. Irrigated tip catheters for radiofrequency ablation in ventricular tachycardia[EB/OL]. Biomed Res Int,2015,2015:389294.
[27] Ozcan C, Ruskin J, Mansour M. Cryoballoon catheter ablation in atrial fibrillation[EB/OL]. Cardiol Res Pract,2011,2011:256347.
[28] Beukema RP, Beukema WP, Smit JJJ, et al. Efficacy of multi-electrode duty-cycled radiofrequency ablation for pulmonary vein disconnection in patients with paroxysmal and persistent atrial fibrillation[J]. Europace,2010,12(4):502-507.
[29] Aagaard P, Natale A, di Biase L. Robotic navigation for catheter ablation: benefits and challenges[J]. Expert Rev Med Devices,2015,12(4):457-469.
[30] Rillig A, Meyerfeldt U, Tilz RR, et al. Incidence and long-term follow-up of silent cerebral lesions after pulmonary vein isolation using a remote robotic navigation system as compared with manual ablation[J]. Circ Arrhythm Electrophysiol,2012,5(1):15-21.
[31] Ren JF, Marchlinski FE, Callans DJ, et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast[J]. J Cardiovasc Electrophysiol,2005,16(5):474-477.
[32] Khan IA. Atrial stunning: determinants and cellular mechanisms[J]. Am Heart J,2003,145(5):787-794.
[33] Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design[J]. J Interv Card Electrophysiol Int J Arrhythm Pacing,2012,33(2):171-257.
[34] Koca V, Bozat T, Akkaya V, et al. Left atrial thrombus detection with multiplane transesophageal echocardiography:an echocardiographic study with surgical verification[J]. J Heart Valve Dis,1999,8(1):63-66.
[35] Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study[J]. Circulation,1994,89(6):2509-2513.
[36] Lee DSY, Dorian P, Downar E, et al. Thrombogenicity of radiofrequency ablation procedures:what factors influence thrombin generation? [J]. Europace,2001,3(3):195-200.
[37] Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation:identification with intracardiac echocardiography[J]. J Am Coll Cardiol,2004,43(10):1861-1867.
[38] Deneke T, Nentwich K, Schmitt R, et al. Exchanging catheters over a single transseptal sheath during left atrial ablation is associated with a higher risk for silent cerebral events[J]. Indian Pacing Electrophysiol J,2014,14(5):240-249.
[39] Maleki K, Mohammadi R, Hart D, et al. Intracardiac ultrasound detection of thrombus on transseptal sheath:incidence, treatment, and prevention[J]. J Cardiovasc Electrophysiol, 2005,16(6):561-565.
[40] McRury ID, Panescu D, Mitchell MA,et al. Nonuniform heating during radiofrequency catheter ablation with long electrodes monitoring the edge effect[J]. Circulation,1997, 96(11):4057-4064.
[41] Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation impact on outcome and complications[J]. Circulation, 2003,107(21):2710-2716.
[42] Haines DE, Stewart MT, Ahlberg S, et al. Microembolism and catheter ablation I:a comparison of irrigated radiofrequency and multielectrode-phased radiofrequency catheter ablation of pulmonary vein ostia[J]. Circ Arrhythm Electrophysiol,2013,6(1):16-22.
[43] Whittaker DK. Mechanisms of tissue destruction following cryosurgery[J]. Ann R Coll Surg Engl,1984,66(5):313-318.
[44] Khairy P, Chauvet P, Lehmann J, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation[J]. Circulation,2003,107(15):2045-2050.
[45] Ma X, Wu T, Robich MP. Drug-eluting stent coatings[J]. Interv Cardiol,2012,4(1):73-83.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[3]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[4]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[5]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[6]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[7]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(1):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[8]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(1):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[9]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(1):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[10]范新荣,等.心房颤动药物治疗的新靶点[J].心血管病学进展,2015,(5):584.[doi:10.3969/j.issn.1004-3934.2015.05.015]
FAN Xinrong,ZENG Xiaorong,et al.Novel Targets of Pharmacological Therapies at Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(1):584.[doi:10.3969/j.issn.1004-3934.2015.05.015]
[11]蒋靖波,钟国强.心房颤动导管消融中脑卒中和无症状脑梗死的预防[J].心血管病学进展,2015,(6):743.[doi:10.3969/j.issn.1004-3934.2015.06.022]
JIANG Jingbo,ZHONG Guoqiang.Strategies to Prevent Periprocedural Stroke and Subclinical Cerebral Emboli in
Patients Undergoing Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(1):743.[doi:10.3969/j.issn.1004-3934.2015.06.022]